激动剂和抑制剂
在生物化学和药物化学领域中,激动剂和抑制剂是调节受体活性的重要分子类型。
激动剂:激动剂是指能够与特定受体结合并激活该受体,从而引起细胞内信号传递的化合物。它们通过与受体的特定位点相互作用,模拟天然配体的功能,导致生物效应的发生或增强。根据其对受体的作用机制不同,激动剂可以分为完全激动剂和部分激动剂。
完全激动剂:能够完全激活受体,达到最大生物活性。
部分激动剂:仅能部分地激活受体,即使在高浓度下也不表现出最大效应。
抑制剂:抑制剂则是相反的一类分子,它们通过与受体或其相关蛋白质结合来阻止信号传导过程。根据作用机制的不同,可以分为竞争性抑制剂和非竞争性抑制剂。
竞争性抑制剂:这些物质通过占据活性位点而减少激动剂的结合能力,通常可以通过增加激动剂浓度来克服这种抑制效应。
非竞争性抑制剂:这类抑制剂不依赖于受体结合部位,而是通过其他方式干扰信号传递,如改变受体构象或直接与G蛋白相互作用。
在药物研发过程中,激动剂和抑制剂的研究至关重要。它们不仅用于治疗疾病,还可以帮助理解生物系统的工作原理。例如,在神经科学领域,激动剂可以被用作治疗抑郁、焦虑等精神疾病的药物;而在癌症研究中,则可能使用抑制剂来阻断促进肿瘤生长的信号通路。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (4-cyclopropylpiperazin-1-yl)(4-(morpholinomethyl)phenyl)methanone dihydrochloride | 929622-09-3 | C19H27N3O2*2ClH |
|
—— | (5α)-pregnane-3β,20α<sub>F</sub>-diol | 80-89-7 | C21H36O2 |
|
—— | 3-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxo-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid | 1345982-69-5 | C28H38N2O7S |
|
—— | Pregnanediol V | 80-89-7 | C21H36O2 |
|
—— | (5α)-pregnane-3α,20α<sub>F</sub>-diol | 80-89-7 | C21H36O2 |
|
—— | N-(8-{[(2R)-2-hydroxy-3-(morpholin-4-yl)propyl]oxy}-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylpyridine-3-carboxamide | 1375469-38-7 | C25H30N6O5 |
|
—— | tenapanor | 1234423-95-0 | C50H66Cl4N8O10S2 |
|
—— | Belizatinib | 1357920-84-3 | C33H44FN5O3 |
|
—— | JNJ-28312141 | 885692-52-4 | C26H32N6O2 |
|
—— | (Z)-2-(3,4-dimethoxy-phenyl)-3-[5-(4-hydroxy-piperidin-1-yl)-thiophen-2-yl]-acrylonitrile | 912287-56-0 | C20H22N2O3S |
|
—— | bleomycin B1 | 11056-06-7 | C50H73N17O21S2 |
|
—— | MK-0773 | 606101-58-0 | C27H34FN5O2 |
|
—— | KNK437 | 218924-25-5 | C13H11NO4 |
|
—— | 2-amino-9-(2-deoxy-pentofuranosyl)-1,9-dihydro-purine-6-thione | 789-61-7 | C10H13N5O3S |
|
—— | avibactam | 1192491-61-4 | C7H10N3O6S*Na |
|
—— | evobrutinib | 1415823-73-2 | C25H27N5O2 |
|
—— | ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)-[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine succinate | 851916-42-2 | C4H6O4*C24H34F3N3O3 |
|
—— | sutezolid | 168828-58-8 | C16H20FN3O3S |
|
—— | telratolimod | 1359993-59-1 | C36H59N5O2 |
|
—— | GSK-3326595 | 1616392-22-3 | C24H32N6O3 |
|
—— | elbasvir | 1370468-36-2 | C49H55N9O7 |
|
—— | 1,4-bis((E)-5-(3,4,5-trimethoxyphenyl)pent-4-enyl)-1,4-diazepane | 191089-59-5 | C33H48N2O6 |
|
—— | osilodrostat | 928134-65-0 | C13H10FN3 |
|
—— | (2R)-2-(4-fluorophenyl)-N-[4-(2-{[2-methoxy-4-(methylsulfonyl)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]propanamide | 1443763-60-7 | C29H26FN5O4S |
|
—— | (1aR,12bS)-8-cyclohexyl-N-[(dimethylamino)sulfonyl]-1,1a,2,12b-tetrahydro-11-methoxy-1a-[(3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl]-cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxamide | 958002-33-0 | C36H45N5O5S |
|
—— | Δ<sup>1</sup>-Dehydrotestololacton | 968-93-4 | C19H24O3 |
|
—— | MK-6096 | 1088991-73-4 | C24H25FN4O2 |
|
—— | 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione | 1265965-22-7 | C22H22N4O4S |
|
—— | DBPR108 | 1186426-66-3 | C16H25FN4O2 |
|
—— | hexadecyloxypropyl-cidofovir | 444805-28-1 | C27H52N3O7P |
|
—— | DY 131 | 95167-41-2 | C18H21N3O2 |
|
—— | potassium canrenoate | 2181-04-6 | C22H29O4*K |
|
—— | Eliglustat Tartrate | 928659-70-5 | C50H78N4O14 |
|
—— | (+/-)-YS-49 | 132836-42-1 | C20H19NO2 |
|
—— | 6-ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide | 1186231-83-3 | C28H31F3N4O6 |
|
—— | Pf-04447943 | 1082744-20-4 | C20H25N7O2 |
|
—— | (2Z,5Z)-3-ethyl-2-[(1-ethylpyridin-1-ium-2-yl)methylidene]-5-(3-methyl-1,3-benzothiazol-2-ylidene)-1,3-thiazolidin-4-one;chloride | 147366-41-4 | C21H22ClN3OS2 |
|
—— | (5E)-3-ethyl-2-[(1-ethylpyridin-1-ium-2-yl)methylidene]-5-(3-methyl-1,3-benzothiazol-2-ylidene)-1,3-thiazolidin-4-one;chloride | 1427472-75-0 | C21H22ClN3OS2 |
|
—— | RO-4917523 | 802906-73-6 | C18H13ClFN3 |
|
—— | Tanzisertib | 899805-25-5 | C21H23F3N6O2 |
|
—— | N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide | 1474110-21-8 | C25H35NO5S |
|
—— | Tesevatinib | 781613-23-8 | C24H25Cl2FN4O2 |
|
—— | N-(2-{[[(2E)-3-(4-chlorophenyl)prop-2-enyl](methyl)amino]methyl}phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide | 139298-40-1 | C26H29ClN2O4S |
|
—— | angelicin | 151823-14-2 | C11H6O3 |
|
—— | (trans)-2-(2-{2-[2-(4-trifluoromethylphenyl)vinyl]-1H-benzimidazol-5-yl}phenyl)propan-2-ol | 956274-94-5 | C25H21F3N2O |
|
—— | (2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3S,4S,5R)-3-methoxy-1-[(2S)-2-[(1S,2S)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | 110417-88-4 | C42H68N6O6S |
|
—— | 4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one HCl salt | 1448754-43-5 | C21H16F3N3O3*ClH |
|
—— | (9H-fluoren-9-yl)methyl ((S)-3-methyl-1-(((S)-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-1-oxobutan-2-yl)carbamate | 863971-53-3 | C40H42N6O10 |
|
—— | 6,7-dimethoxy-4-phenylaminoquinazoline | 21561-09-1 | C16H15N3O2 |
|
—— | 5α-cholestan-3-one | 566-88-1 | C27H46O |
|